Pre-hypertension Clinical Trial
Official title:
Personalized Blood Pressure Care for Prehypertensive Patients Using IoMTs and Artificial Intelligence
NCT number | NCT04543656 |
Other study ID # | 1 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | October 1, 2020 |
Est. completion date | June 2022 |
In this RCT, up to 100 adults classified as pre-hypertensive will be randomized to either an artificial intelligence (AI) based lifestyle intervention group or an active control group with a 1 to 1 ratio. Both groups will receive an identical activity tracker (Samsung Galaxy Watch) and BP monitor (Omron Evolv). The AI intervention group will receive automated and personalized lifestyle recommendations based on their lifestyle (e.g. sleep, exercise and diet) and blood pressure (BP) data, involving an automated analytics engine using statistics and machine learning. The active control group will not receive these lifestyle recommendations. The investigators aim to assess objectively the effectiveness of the AI-based personalized lifestyle recommendations on the patients BP.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | June 2022 |
Est. primary completion date | June 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - age =18 years - SBP between 130 mmHg to 139 mmHg or/and DBP between 80 to 89 mmHg in a research office - speaking and reading English - having an iPhone 8 or newer or an Android x or newer Exclusion Criteria: - currently taking antihypertensive medication - self-reported diagnosis of coronary heart disease, medical condition or other physical problem necessitating special attention in an exercise program (e.g., cancer, eating disorder, uncontrolled diabetes) - current participation in a lifestyle modification program or research study - self-report of being currently pregnant |
Country | Name | City | State |
---|---|---|---|
United States | University of California, San Diego | La Jolla | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Diego |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Average change in systolic blood pressure (SBP) in experimental vs. control group | Average SBP during the first and last week of a patient's enrollment will be used to calculate SBP change for each patient. | Initial 2 week data collection, weekly lifestyle recommendations, 6 months total | |
Primary | Average change in diastolic blood pressure (DBP) in experimental vs. control group | Average DBP during the first and last week of a patient's enrollment will be used to calculate DBP change for each patient. | Initial 2 week data collection, weekly lifestyle recommendations, 6 months total | |
Secondary | Number of patients in experimental group that followed lifestyle recommendations | This secondary outcome measure is interested in assessing patient engagement within the experimental group. Data from the activity tracker (steps, sleep quality, active minutes, etc.) will be used to assess whether a patient followed the lifestyle recommendations. | Initial 2 week data collection, weekly lifestyle recommendations, 6 months total |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03313284 -
Respiratory Muscle Training and Intermittent Hypoxia: Additive Health Effects?
|
N/A | |
Completed |
NCT01741779 -
Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function
|
N/A | |
Withdrawn |
NCT01074918 -
Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients
|
Phase 1/Phase 2 | |
Completed |
NCT00288158 -
Primary Prevention of Hypertension in Obese Adolescents
|
Phase 2 | |
Completed |
NCT01190319 -
Study: Effects of Strawberries on Blood Pressure
|
N/A | |
Completed |
NCT01008176 -
Restoring Sleep Homeostasis to Lower Blood Pressure
|
N/A | |
Unknown status |
NCT02197910 -
Different Dosages of Bioactive Wheat Peptides and Blood Pressure Level and CVD Risk Biomarkers in Healthy Subjects
|
N/A | |
Completed |
NCT03168789 -
Tension Tamer Randomized Control Trial
|
N/A | |
Completed |
NCT00553969 -
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00170937 -
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
|
Phase 4 | |
Completed |
NCT01741766 -
The Effects of Stretching Training on Arterial Function and Autonomic Control
|
N/A | |
Completed |
NCT02143817 -
Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition
|
N/A | |
Terminated |
NCT00388388 -
Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
|
Phase 2 | |
Completed |
NCT02148458 -
Short Term Intermittent Fasting and Mediterranean Diet
|
N/A | |
Terminated |
NCT01349114 -
Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects
|
Phase 4 | |
Completed |
NCT02038179 -
Center of Research Translation (CORT) Project 2
|
Phase 2/Phase 3 | |
Completed |
NCT00970931 -
Hypertension Prevention in Pre-Hypertensive Individuals
|
Phase 3 | |
Completed |
NCT01202175 -
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension
|
Phase 4 | |
Not yet recruiting |
NCT01364675 -
Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects
|
N/A | |
Completed |
NCT01841840 -
The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke
|
N/A |